Modelling of the cancer cell cycle as a tool for rational drug development: A systems pharmacology approach to cyclotherapy.
The dynamic of cancer is intimately linked to a dysregulation of the cell cycle and signalling pathways. It has been argued that selectivity of treatments could exploit loss of checkpoint function in cancer cells, a concept termed "cyclotherapy". Quantitative approaches that describe these...
Main Authors: | Robert C Jackson, Giovanni Y Di Veroli, Siang-Boon Koh, Ian Goldlust, Frances M Richards, Duncan I Jodrell |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-05-01
|
Series: | PLoS Computational Biology |
Online Access: | http://europepmc.org/articles/PMC5435348?pdf=render |
Similar Items
-
ARVI: rational pharmacotherapy from the standpoint of clinical pharmacology
by: N. B. Lazareva, et al.
Published: (2016-12-01) -
Inventories, rational expectations and the business cycle
by: Blinder, Alan S., et al.
Published: (2011) -
Unravelling the rationalities of childhood cycling promotion
by: Jonne Silonsaari, et al.
Published: (2022-06-01) -
Rational limit cycles of Abel differential equations
by: José Luis Bravo, et al.
Published: (2023-12-01) -
Rational Limit Cycles on Abel Polynomial Equations
by: Claudia Valls
Published: (2020-06-01)